Abstract
To determine the efficacy of tenofovir disoproxil fumarate (TDF) in adults with chronic hepatitis B virus (HBV) infection who had previously failed lamivudine (LAM) and had significant viral replication (HBV DNA >10a?? copies/ml if HBeAg positive, > 10a? copies/ml if HBeAg negative) despite at least 24 weeks of treatment with adefovir dipivoxil (ADV).
Original language | English |
---|---|
Pages (from-to) | 247 - 254 |
Number of pages | 8 |
Journal | Gut |
Volume | 60 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2011 |